Palleos is proud to announce a collaboration with TrialHub, an award-winning clinical trials data platform, to further patient education and advocacy. This partnership includes the donation of a full European Patients’ Academy (EUPATI) scholarship, empowering a patient representative with the knowledge and skills to contribute meaningfully to the development of new therapies.
The EUPATI scholarship reflects Palleos’ dedication to fostering a more inclusive and informed patient community, vital for the success of clinical trials. By combining its expertise in clinical research with TrialHub’s innovative approach to data and patient engagement, the company aims to accelerate the development of life-changing medical innovations.
“Partnering with TrialHub to support patient education aligns perfectly with our mission to advance patient-centric clinical research. By donating this EUPATI scholarship, we aim to foster a more inclusive and informed patient community, which is crucial for the success of clinical trials and the development of new therapies,” said Philip Raeth, Managing Director, Palleos.”
Maya Zlatanova, CEO of TrialHub, commented, “This collaboration represents a significant step towards more patient-inclusive clinical research. We believe that educated and engaged patients are key to driving innovation and improving outcomes in clinical trials. We are excited to support this initiative and look forward to seeing the positive impact it will have on the recipient and the broader patient community.”
